• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: comparison bet

Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: comparison bet

来源 :第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu | 被引量 : 0次 | 上传用户：flyballball
【摘 要】
：
The objective of this study was to assess ethnic difference of mycophenolic acid (MPA) and 7-Omycophenolic acid glucuronide (MPAG) pharmacokinetics (PK) among Chinese and Caucasian healthy subjects by
【作 者】
：
Jing Ling Jun Shi Zheng Jiao 
【机 构】
：
Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, 200040, P.R.CHINA
【出 处】
：
第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu
【发表日期】
：
2013年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　The objective of this study was to assess ethnic difference of mycophenolic acid (MPA) and 7-Omycophenolic acid glucuronide (MPAG) pharmacokinetics (PK) among Chinese and Caucasian healthy subjects by population PK analysis.Data were pooled from eight studies with total of 80 Chinese and 52 Caucasian administrated with a single oral dose of Mycophenolate mofetil (MMF).
其他文献
Integrated Population Pharmacokinetic/Viral Dynamic Modeling of Lopinavir/Ritonavir in HIV-1 Treatme
Background: Lopinavir (LPV)/ritonavir (RTV) co-formulation (LPV/r) is a widely used protease inhibitor (PI) based regimen to treat HIV-infection.As with all PIs, the trough concentration (C 12h) is a
会议
A Mechanistic Pharmacokinetic-Pharmacodynamic Model for the Effect of Esomeprazole in Healthy Subjec
Esomeprazole has proved to be effective for the treatment of gastroesophogeal reflux disease (GERD) and ulcers, where intra-gastric pH value is a biomarker to indicate esomeprazole effects on these di
会议
A Pop-PK Analysis of Ceftizoxime in Healthy Chinese Adults and Elder Subjects
Background: The distribution of renal function and its effect on drug elimination was not well understood in Chinese population, which impeded the clinical therapeutics for Chinese patients as well as
会议
Sequential Population Pharmacokinetic and Pharmacodynamic Modeling of Rivaroxaban in Adult and Elder
Aim:Rivaroxaban (Bayer Healthcare AG, Wuppertal, Germany), an oral, direct factor Xa (FXa) inhibitor for the prevention and treatment of thromboembolic disorders has been approved for nonvalvular atri
会议
Pharmacokinetic-pharmacodynamic modeling of the anticancer effect of erlotinib in a human non-small
Aim:Erlotinib is used to treat non-small-cell lung cancer (NSCLC), which targets epidermal growth factor receptor (EGFR) tyrosine kinase.The aim of this study was to investigate the relationship betwe
会议
non-small-cell lung canceranticancer drugerlotinibepidermal growth factor rec
Preclinical Pharmacokinetic/Pharmacodynamic Models to Predict Schedule-Dependent Interaction Between
Purpose:To investigate the pharmacological effects of differenterlotinib (ER) and gemcitabine (GM) combination schedules byin vitro and in vivo experiments and PK/PD models in non-smallcell lung cance
会议
Pediatric physiologically based pharmacokinetic model and its applications in pediatric drug researc
Pediatric drug research is currently one of the new frontiers for clinical pharmacology.With the necessity of pediatric drug research and the special ethical considerations in pediatric clinical trial
会议
TOWARDS QUANTITATIVE PREDICTION OF IN VIVO BRAIN PENETRATION USING A PHYSIOLOGY BASED CNS DISPOSITIO
INTRODUCTION Drug discovery for central nervous system (CNS) disorders has been challenged with markedly high attrition rate.This has driven extensive preclinical and clinical CNS pharmacokinetic (PK)
会议
Apply established exposure-response model with different mechanism of actions to guide clinical tria
Background: Exposure-response model has been established in patients with psoriasis for Ustekinumab, a human immunoglobulin G1 kappa (IgG1k) monoclonal antibody that binds with high affinity to human
会议
Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers
AIM: To develop a population pharmacokinetic model of adefovir dipivoxil in healthy volunteers and evaluate the effect of individual factors on the pharmacokinetics of adefovir dipivoxil.METHODS: Plas
会议